Long COVID-19 Symptoms Remedied by Anti-Viral Treatment in Neurosurgical Patients
Robert Michael Beatty1 Show affiliations
- Neurosurgery, Beatty LLC, Fairway, KS, United States
American Journal of Infectious Diseases, Volume 19, Issue 3, pp. 39–44 · doi.org/10.3844/ajidsp.2023.39.44
Abstract
The pandemic of COVID-19 is the largest in this century. Aside from the acute infection, some of the patients have been challenged with a complication that is known as long COVID-19. The symptoms of long COVID-19 are extensive and diverse. Long COVID-19 continues to plague many patients post-COVID-19 infection. No universal treatment has been found. This study presents four patients who suffered from long COVID-19. Each patient presented with a different and diverse symptom of long COVID-19. Each of the patient's symptoms resolved or greatly improved upon taking the anti-viral drug acyclovir. Acyclovir has been in use since 1981 and is generally considered safe. A novel theory as to the pathophysiology of long COVID-19 symptoms and the result of a new treatment is presented. The purpose of this study is to provide a foundation for much bigger studies and useful resources for further testing to halt long COVID-19.
Licence and reuse
Open access. This article is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.
How to reuse this articleResponses (0)
About this article
Beatty, R. M. (2023). Long COVID-19 Symptoms Remedied by Anti-Viral Treatment in Neurosurgical Patients. American Journal of Infectious Diseases, 19(3), 39–44. https://doi.org/10.3844/ajidsp.2023.39.44
- Licence
- CC BY 4.0
- Issue
- Volume 19, Issue 3
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
